文献速递糖尿病

WFS1基因相关糖尿病表型及南印度奠基者突变的鉴定

WFS1 Gene-associated Diabetes Phenotypes and Identification of a Founder Mutation in Southern India.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

本病例系列通过下一代测序(NGS)对17个单基因糖尿病基因 panel 筛查11例WFS1变异阳性患者,其中9例为WFS1致病/可能致病变异纯合子,3例检出新型WFS1 c.1107_1108insA(p.Ala370Serfs*173)变异且单倍型分析提示南印度3个家系存在奠基者效应,另2例青年起病糖尿病为WFS1杂合变异。结论认为需NGS平行多基因检测以早期诊断Wolfram综合征并识别与青年起病糖尿病相关的WFS1杂合变异。

要点

  • 11例WFS1变异阳性患者中9例为致病/可能致病变异纯合子。
  • 3例先证者携带新型WFS1 c.1107_1108insA(p.Ala370Serfs*173)变异,单倍型分析提示南印度3个家系奠基者效应。
  • 2例青年起病糖尿病为WFS1可能致病或意义不明变异杂合子。

核心结论

  • 结果提示需以NGS平行多基因检测作为早期诊断Wolfram综合征的工具,并识别与青年起病糖尿病相关的WFS1杂合变异。

研究设计与样本

  • 病例系列,11例WFS1变异阳性患者,通过基于NGS的17个单基因糖尿病基因 panel 筛查识别,结果经Sanger测序确认。

主要发现

  • 11例患者中9例为WFS1基因致病/可能致病变异纯合子。
  • 3例先证者携带新型WFS1(NM_006005.3):c.1107_1108insA(p.Ala370Serfs*173)变异,单倍型分析提示南印度3个家系存在奠基者效应。
  • 另发现2例青年起病糖尿病患者为WFS1基因可能致病变异或意义不明变异杂合子。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Wolfram syndrome (WFS) is a rare autosomal recessive disorder characterized by juvenile-onset diabetes, diabetes insipidus, optic atrophy, deafness, and progressive neurodegeneration. However, due to the progressive nature of the disease and a lack of complete clinical manifestations, a confirmed diagnosis of WFS at the time of onset of diabetes is a challenge. OBJECTIVE: With WFS1 rare heterozygous variants reported in diabetes, there is a need for comprehensive genetic screening strategies for the early diagnosis of WFS and delineating the phenotypic spectrum associated with the WFS1 gene variants in young-onset diabetes. METHODS: This case series of 11 patients who were positive for WFS1 variants were identified with next-generation sequencing (NGS)-based screening of 17 genemonogenic diabetes panel. These results were further confirmed with Sanger sequencing. RESULTS: 9 out of 11 patients were homozygous for pathogenic/likely pathogenic variants in the WFS1 gene. Interestingly, 3 of these probands were positive for the novel WFS1 (NM_006005.3): c.1107_1108insA (p.Ala370Serfs*173) variant, and haplotype analysis suggested a founder effect in 3 families from Southern India. Additionally, we identified 2 patients with young-onset diabetes who were heterozygous for a likely pathogenic variant or a variant of uncertain significance in the WFS1 gene. CONCLUSION: These results project the need for NGS-based parallel multigene testing as a tool for early diagnosis of WFS and identify heterozygous WFS1 variants implicated in young-onset diabetes.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Chapla A, Johnson J, Korula S, et al. WFS1 Gene-associated Diabetes Phenotypes and Identification of a Founder Mutation in Southern India. J Clin Endocrinol Metab. 2022. PMID: 35018440. doi:10.1210/clinem/dgac002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。